Literature DB >> 28894045

Neopterin as a marker of cellular immunological response.

Łukasz Michalak1, Magdalena Bulska2, Karolina Strząbała2, Piotr Szcześniak2.   

Abstract

Neopterin is a pyrazino-pyrimidine compound that belongs to the pteridine group. It is known to be a biochemical marker associated with cell-mediated immunity. It is produced by human monocytes/macrophages and dendritic cells from guanosine triphosphate (GTP) upon stimulation with interferon gamma (IFNγ), which is released by activated limphocytes Th. Neopterin is a very important clinic parameter, though the physiological role has not been exactly definited thus far. The level of neopterin reflects the stage of activation of the cellular immune system, which is important in the pathogenesis and progression of various diseases. Measuring its concentration in body fluids is used in many different areas of modern medicine, such as infectious disease, gastroenterology, transplantology and transfusiology, rheumatology or oncology. In neurological, cardio-vascular and autoimmune diseases, cell-mediated immunity is also activated, which is proved by the elevated level of this marker. Measurements of neopterin concentrations are also helpful in monitoring the therapy of patients infected with the HIV virus or treated by using immunomudulating therapy. As a result of measuring levels of neopterin in patients with neoplasms of digestive tract, increased concentration was proved, but it is not routinely used in everyday clinic practice.

Entities:  

Keywords:  Neopterin; makrofagi; monocyty; neopteryna; nowotwory; odporność immunologiczna typu komórkowego; pteridin; pterydyna

Mesh:

Substances:

Year:  2017        PMID: 28894045     DOI: 10.5604/01.3001.0010.3851

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  8 in total

1.  Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy.

Authors:  Rowan Saloner; Natalie Savini; Scott L Letendre; David J Moore; Jessica L Montoya
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-01       Impact factor: 3.771

2.  Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?

Authors:  Mehran Mohareri; Ali Mirhosseini; Saeedeh Mehraban; Bahare Fazeli
Journal:  Vasc Health Risk Manag       Date:  2018-09-28

3.  Identification of neurodegeneration indicators and disease progression in metachromatic leukodystrophy using quantitative NMR-based urinary metabolomics.

Authors:  Lucia Laugwitz; Laimdota Zizmare; Vidiyaah Santhanakumaran; Claire Cannet; Judith Böhringer; Jürgen G Okun; Manfred Spraul; Ingeborg Krägeloh-Mann; Samuel Groeschel; Christoph Trautwein
Journal:  JIMD Rep       Date:  2022-01-27

Review 4.  The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity.

Authors:  Yousef Rasmi; Nadia Heidari; Kevser Kübra Kırboğa; Shima Hatamkhani; Burcu Tekin; Shahryar Alipour; Roya Naderi; Yeghaneh Farnamian; Ilknur Akca
Journal:  Clin Biochem       Date:  2022-03-17       Impact factor: 3.625

5.  Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.

Authors:  Dilek Tezcan; Duygu Eryavuz Onmaz; Abdullah Sivrikaya; Selda Hakbilen; Muslu Kazım Körez; Semral Gülcemal; Sema Yılmaz
Journal:  Ir J Med Sci       Date:  2022-09-26       Impact factor: 2.089

6.  Neopterin, procalcitonin, clinical biochemistry, and hematology in calves with neonatal sepsis.

Authors:  Enes Akyüz; Gürbüz Gökce
Journal:  Trop Anim Health Prod       Date:  2021-06-09       Impact factor: 1.559

7.  Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers.

Authors:  Amer Khojah; Gabrielle Morgan; Lauren M Pachman
Journal:  Diagnostics (Basel)       Date:  2021-12-21

Review 8.  The potential role of neopterin in Covid-19: a new perspective.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb; Khalid J Alzahrani; Natália Cruz-Martins; Gaber El-Saber Batiha
Journal:  Mol Cell Biochem       Date:  2021-07-28       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.